John O Holloszy Selected Research

John O Holloszy Research Topics

Disease

30	Insulin Resistance 01/2019 - 01/2002
7	Weight Loss (Weight Reduction) 07/2009 - 07/2005
5	Type 2 Diabetes Mellitus (MODY) 04/2013 - 01/2009
4	Inflammation (Inflammations) 01/2016 - 08/2007
4	Hypoxia (Hypoxemia) 11/2012 - 01/2002
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 11/2004
3	Glucose Intolerance 05/2011 - 02/2005
3	Neoplasms (Cancer) 04/2010 - 12/2006
3	Body Weight (Weight, Body) 10/2008 - 03/2005
2	Frailty 11/2005 - 12/2002
2	Obesity 07/2005 - 02/2005
1	Hypersensitivity (Allergy) 01/2016
1	Infections 01/2016
1	Iron Deficiencies 05/2011
1	Overweight 05/2011
1	Chronic Disease (Chronic Diseases) 04/2010
1	Malnutrition (Nutritional Deficiencies) 10/2008
1	Coronary Disease (Coronary Heart Disease) 01/2005
1	Abdominal Obesity 11/2004
1	Atherosclerosis 04/2004
1	Mitochondrial Diseases (Mitochondrial Disease) 03/2004
1	Hypertension (High Blood Pressure) 06/2002

Drug/Important Bio-Agent (IBA)

23	Insulin (Novolin)FDA Link 01/2019 - 01/2002
21	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2002
7	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2002
5	LipidsIBA 01/2019 - 03/2004
4	Fatty Acids (Saturated Fatty Acids)IBA 05/2011 - 02/2005
3	Insulin-Like Growth Factor I (IGF-1)IBA 02/2014 - 10/2008
2	C-Reactive ProteinIBA 01/2019 - 08/2007
2	ginsenoside ReIBA 11/2012 - 05/2011
2	Dehydroepiandrosterone (DHEA)IBA 05/2011 - 11/2004
2	Triiodothyronine (Liothyronine)FDA LinkGeneric 03/2010 - 08/2007
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2016
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2016
1	VaccinesIBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 02/2014
1	C-PeptideIBA 02/2012
1	Citrate (si)-Synthase (Synthase, Citrate)IBA 05/2011
1	EnzymesIBA 05/2011
1	Long-Chain Acyl-CoA Dehydrogenase (Long-Chain-Acyl-Coenzyme A Dehydrogenase)IBA 05/2011
1	Citric Acid (Citrate)FDA LinkGeneric 05/2011
1	IronIBA 05/2011
1	Oleic Acid (Oleate)IBA 05/2011
1	CytokinesIBA 05/2011
1	Gonadal Steroid Hormones (Sex Hormones)IBA 04/2010
1	Testosterone (Sustanon)FDA Link 03/2010
1	AdiponectinIBA 03/2010
1	Triglycerides (Triacylglycerol)IBA 07/2009
1	Heparin (Liquaemin)FDA LinkGeneric 07/2009
1	Nonesterified Fatty Acids (NEFA)IBA 07/2009
1	Insulin-Like Growth Factor Binding Protein 3IBA 10/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2007
1	Interleukin-6 (Interleukin 6)IBA 06/2007
1	Anabolic AgentsIBA 02/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2006
1	Hormones (Hormone)IBA 12/2006
1	AMP-Activated Protein KinasesIBA 07/2005
1	p38 Mitogen-Activated Protein KinasesIBA 07/2005
1	Dantrolene (Dantrium)FDA LinkGeneric 06/2005
1	KN 93IBA 06/2005
1	AnisomycinIBA 04/2005
1	4- (4- fluorophenyl)- 2- (4- hydroxyphenyl)- 5- (4- pyridyl)imidazoleIBA 04/2005
1	Calcineurin InhibitorsIBA 03/2005
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2005
1	PPAR alphaIBA 02/2005
1	Lipoproteins (Lipoprotein)IBA 01/2005
1	Protein Kinase CIBA 08/2004
1	Protein Isoforms (Isoforms)IBA 08/2004
1	calpastatinIBA 05/2004
1	Dactinomycin (Actinomycin)FDA LinkGeneric 12/2003
1	Glucosamine (Dona)IBA 12/2003
1	Uridine Diphosphate (UDP)IBA 12/2003
1	Oxygen (Dioxygen)IBA 12/2002
1	Uncoupling Protein 1IBA 06/2002
1	Cycloheximide (Cicloheximide)IBA 01/2002
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2002
1	AICA ribonucleotide (ZMP)IBA 01/2002
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2002

Therapy/Procedure

5	Caloric Restriction 03/2008 - 04/2004
2	Activities of Daily Living (ADL) 11/2005 - 12/2002
1	Therapeutics 05/2011